How New Ultrasound Technology Detects Middle Ear Infections in Under 2 Secs
OtoNexus Medical Technologies has built a revolutionary ear ultrasound otoscope that represents a significant advancement in detecting middle ear infections (otitis media). Unlike traditional methods that rely on subjective visual inspection, the OtoNexus otoscope uses a proprietary new ultrasound technology technique to provide clear, objective data about the type of middle ear infection in seconds. This new technology has been miniaturized to fit into the tip of an ear speculum and will allow clinicians to determine when a bacterial middle ear infection is present and give them the information they need to prescribe antibiotics judiciously.
OtoNexus middle ear infection detection with ultrasound technology
This new otitis media medical device resembles a traditional otoscope and can fit in a lab coat pocket, but that is where the similarities end. With the advanced ultrasound otoscope, clinicians simply push a button to get the results they need. A proprietary algorithm analyzes the data to identify fluid presence and fluid type within seconds. Surgical correlation studies and microbiota analysis have validated these results for accuracy.
This definitive data has never been available without an invasive procedure. Integrating this technology will enable a novice to expert clinician to obtain consistent quantitative measurements and reduce the time to diagnosis by simplifying the testing process.
Key Features:
OtoNexus medical technologies ultrasound otoscope for accurate detection of middle ear infections (otitis media)
Instant Results: The OtoNexus ultrasound otoscope delivers data within seconds, allowing for immediate clinical decisions.
Ease of Use: Designed for use by physicians, nurse practitioners, and physician assistants, the device is straightforward, user-friendly, and fits into existing clinical workflows with minimal training. Measurement is automated, and the device initiates measurement when conditions are optimal.
Disposable Tips: Ensures hygiene and provides a recurring revenue model through one-use-per-patient tips.
Universal-Sized Speculum: The ear speculum fits patients of all sizes (newborn to 18 years of age) and simplifies the examination process and inventory management.
Accurate Detection: Capable of detecting middle ear effusion and differentiating between viral and bacterial infections, leading to more precise treatments.
Direct Integration with EMRs: Exam results, images, and videos are easily transferred to electronic medical records, saving time and improving clinical workflows. This integration saves valuable time, facilitates longitudinal patient tracking, and simplifies the referral process to specialists.
Product Development Achievements:
Patented Technology: Our unique proprietary application of through-air ultrasound technology, which has been miniaturized to fit into the tip of an ear speculum, has been patented, ensuring a competitive edge in the market.
Clinical Validation: We have conducted successful clinical studies demonstrating the high accuracy and reliability of the ultrasound otoscope, validating its effectiveness.
Strategic Partnerships: We have established collaborations with leading healthcare institutions and organizations to further our mission and enhance our market reach.
Industry Recognition:
OtoNexus was selected for the elite FDA Safer Technologies Program (STeP) in December of 2023. STeP is a pioneering initiative introduced by the FDA to identify and expedite the development and review of innovative medical devices that offer a significant advantage over all currently available options. Devices selected for the program provide radical improvements in patient care and patient safety. STeP aims to provide patients with more timely access to these medical devices by providing STeP awardees expedited development and review, and interactive and timely communications, including sprint discussions, enhanced regulatory support, real-time feedback and direct advice, and other support. To qualify, the product must offer a significant advantage over currently available options. The evaluation process for the program requires comprehensive due diligence by the FDA to ensure the technology meets the strict, extensive criteria for the STeP program. This is a significant validation of our unique technology and the need for a superior otitis media medical device.
Join Us in Revolutionizing Healthcare
Learn more about our mission to improve the detection and treatment of middle ear infections. By choosing OtoNexus, you support a company dedicated to significantly impacting pediatric patient care and the broader healthcare system. With a strong IP portfolio, a robust recurring revenue stream, and a blue ocean market space, OtoNexus is poised for success as a medtech innovator. For investor information, Find out more here.
OtoNexus Medical Technologies is more than just a promising investment; it’s an opportunity to be part of a disruptive healthcare innovation for detecting and managing otitis media.
Together, we can change the future of pediatric healthcare.